Placebo-Controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy

Annals of Clinical and Translational Neurology - United States
doi 10.1002/acn3.579
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs
Pharmacology
2012English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy

Pediatrics
Child HealthPediatricsPerinatology
2015English

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy